Anne-sophie S. Korganow

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

Journal: RMD open

Published: March 09, 2026

Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].

Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].

Journal: Molecular pharmacology

Published: September 19, 2025

Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.

Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.

Journal: Molecular pharmacology

Published: February 15, 2025

Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice.

Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function mice.

Journal: EMBO molecular medicine

Published: February 06, 2025

Editorial: Community series in primary immunodeficiencies worldwide, volume II.

Editorial: Community series in primary immunodeficiencies worldwide, volume II.

Journal: Frontiers in immunology

Published: January 22, 2025

Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.

Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: September 14, 2024

The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.

The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.

Journal: Frontiers in immunology

Published: September 03, 2024

Histologic and molecular features shared between antibody-mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis.

Histologic and molecular features shared between antibody-mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis.

Journal: The Journal of pathology

Published: August 19, 2024

Evaluation of an integrated activated partial thromboplastin time (Cephen LS/Cephen) for the detection of lupus anticoagulant.

Evaluation of an integrated activated partial thromboplastin time (Cephen LS/Cephen) for the detection of lupus anticoagulant.

Journal: International journal of laboratory hematology

Published: June 13, 2024

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care.

Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care.

Journal: Journal of clinical immunology

Published: April 08, 2024

Correction: An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

Correction: An immunogenomic exome landscape of triple positive primary antiphospholipid patients.

Journal: Genes and immunity

Published: March 20, 2024

CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.

CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.

Journal: The New England journal of medicine

Published: February 21, 2024

Showing 1-12 of 77

Last Updated: 09/26/2026